- Home
- RLMD vs BMRA Comparison
RLMD vs BMRA Comparison
Compare RLMD & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- BMRA
- Stock Information
- Founded
- RLMD 2004
- BMRA 1971
- Country
- RLMD United States
- BMRA United States
- Employees
- RLMD N/A
- BMRA N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RLMD Health Care
- BMRA Health Care
- Exchange
- RLMD Nasdaq
- BMRA Nasdaq
- Market Cap
- RLMD 11.5M
- BMRA 11.2M
- IPO Year
- RLMD N/A
- BMRA N/A
- Fundamental
- Price
- RLMD $0.30
- BMRA $0.57
- Analyst Decision
- RLMD Hold
- BMRA
- Analyst Count
- RLMD 4
- BMRA 0
- Target Price
- RLMD $4.25
- BMRA N/A
- AVG Volume (30 Days)
- RLMD 382.7K
- BMRA 187.3K
- Earning Date
- RLMD 03-27-2025
- BMRA 04-11-2025
- Dividend Yield
- RLMD N/A
- BMRA N/A
- EPS Growth
- RLMD N/A
- BMRA N/A
- EPS
- RLMD N/A
- BMRA N/A
- Revenue
- RLMD N/A
- BMRA $5,578,000.00
- Revenue This Year
- RLMD N/A
- BMRA N/A
- Revenue Next Year
- RLMD N/A
- BMRA N/A
- P/E Ratio
- RLMD N/A
- BMRA N/A
- Revenue Growth
- RLMD N/A
- BMRA 1.40
- 52 Week Low
- RLMD $0.24
- BMRA $0.24
- 52 Week High
- RLMD $5.09
- BMRA $1.27
- Technical
- Relative Strength Index (RSI)
- RLMD 50.05
- BMRA 40.83
- Support Level
- RLMD $0.26
- BMRA $0.55
- Resistance Level
- RLMD $0.32
- BMRA $0.74
- Average True Range (ATR)
- RLMD 0.02
- BMRA 0.05
- MACD
- RLMD 0.00
- BMRA -0.01
- Stochastic Oscillator
- RLMD 67.34
- BMRA 9.84
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.